Sort by
Refine Your Search
-
Bayesian computational methods for such (ill-posed) inverse problems and aims both at increasing their validity and at reducing their computational cost. In this project, we will focus on increasing validity
-
mechanisms that can serve as future targets for early detection, prevention, and treatment. Our lab is at the forefront of Alzheimer’s genetics research, and has a strong international network to enhance gene
-
-epidemiological methods on human study populations to identify molecular mechanisms that can serve as future targets for early detection, prevention, and treatment. Our lab is at the forefront of Alzheimer’s
-
to identify molecular mechanisms that can serve as future targets for early detection, prevention, and treatment. Our lab is at the forefront of Alzheimer’s genetics research, and has a strong international
-
Prof. Maarten Dewilde, is looking for a motivated postdoctoral scientist to join our multidisciplinary project on gene therapy for Alzheimer’s Disease. This work is focused on the specific targeting
-
of theranostic radioligands targeting tumor-associated proteases. Project overview: The Radiopharmacy group has extensive expertise in the development of radiolabeled ligands for proteases implicated in human
-
research activities within the Radiopharmacy (CREANT) department and the Molecular Imaging Center Antwerp (MICA), focusing on the preclinical evaluation of theranostic radioligands targeting tumor
-
our multidisciplinary project on gene therapy for Alzheimer’s Disease. This work is focused on the specific targeting of clinical mutations that cause dominant inherited Alzheimer’s disease using